Searched for
MULTIPLE SCLEROSIS PATIENTS
Zydus gets USFDA nod for generic drug to treat multiple sclerosisZydus Lifesciences has secured USFDA approval to market Glatiramer Acetate Injection, a generic version of Copaxone, for treating relapsing...
AI can have medical care biases too, a study revealsDespite identical clinical details, the AI models occasionally altered decisions based on patients' personal characteristics, affecting pri...
Zydus receives USFDA Orphan Drug Designation for Usnoflast to treat ALSZydus Lifesciences announced that the USFDA granted Orphan Drug Designation to Usnoflast, a novel oral NLRP3 inhibitor, for treating amyotr...
Roche Pharma launches multiple sclerosis treatment drug in IndiaThe company has introduced Ocrevus (Ocrelizumab) which is the first and only approved disease modifying therapy for both Relapsing Remittin...
Research finds long Covid's muscle fatigue linked to depletion of ACE2 receptorsResearchers at the University of Malta have found that depletion of ACE2 receptors, which permit SARS-CoV-2 to enter cells and cause COVID-...
Scientists discover a genetic variant linked to severity of multiple sclerosisScientists have identified a genetic variant that is linked to the severity of multiple sclerosis (MS) and the progression of the disease o...
Former Delhi deputy CM Manish Sisodia's wife Seema Sisodia admitted to Delhi hospitalAam Aadmi Party chief spokesperson and Delhi Cabinet minister Saurabh Bharadwaj said, "Manish ji's wife is suffering from a rare and seriou...
Motorcyclist Maxime Grau on sabbatical due to Epstein-Barr disease. Know more about the virus that causes ‘kissing disease’, cancer & multiple sclerosisThe most common disease caused by this virus is Infectious Mononucleosis (mono).
Commonly found Epstein-Barr virus likely to be linked with multiple sclerosis, say Harvard researchersHarvard researchers reported one of the largest studies yet to back the Epstein-Barr theory.
World Multiple Sclerosis Day: Don't struggle with everyday challenges, treatments can help manage the conditionMS is a chronic neurodegenerative condition that affects the central nervous system.
SPARC stock tumbles 6% on spasticity study resultsThe stock dropped 5.82 per cent to end the session at Rs 336.70 on the BSE.
'Bad' white blood cells responsible for multiple sclerosisRecent clinical trials showed that B cell depletion Therapy (BCDT) in people with relapsing-remitting MS led to dramatic decreases in new d...
Sun Pharma settles patent litigation with Acorda TherapeuticsSun Pharma has settled patent litigation with Acorda Therapeutics over Ampyra extended-release tablets, which is used in the treatment of m...
Biogen Idec gets DCGI nod for multiple sclerosis oral drugThe company has received approval for the first oral therapy drug Tecfidera for multiple sclerosis by DCGI, Biogen Idec Biotech India Pvt L...
Russian doctor rebellion causes headache for president Vladimir PutinOn Sunday, many doctors are set to march against the reform as part of the first mass social protest in Russia in nearly a decade.
- Natco Pharma soars on drug licensing deal
Natco Pharma rose as much as 19 per cent after it struck a licensing and supply deal with US-based Mylan for its generic version of multipl...
- Natco inks agreement with Mylan for Copaxone
Home grown major Natco Pharma today said it has signed a licence and supply agreement with US-based Mylan for the global sale of generic ve...